Revvity Inc. $RVTY Stock Holdings Increased by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio raised its position in shares of Revvity Inc. (NYSE:RVTY) by 33.4% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 98,237 shares of the company’s stock after buying an additional 24,591 shares during the quarter. Public Employees Retirement System of Ohio owned about 0.09% of Revvity worth $8,607,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC increased its holdings in shares of Revvity by 127.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock valued at $171,921,000 after acquiring an additional 980,142 shares during the last quarter. Norges Bank bought a new position in Revvity during the fourth quarter worth $80,382,000. Morgan Stanley boosted its holdings in Revvity by 29.6% in the fourth quarter. Morgan Stanley now owns 2,844,464 shares of the company’s stock worth $275,202,000 after purchasing an additional 650,083 shares during the period. Janus Henderson Group PLC boosted its holdings in Revvity by 7.0% in the fourth quarter. Janus Henderson Group PLC now owns 8,161,171 shares of the company’s stock worth $789,595,000 after purchasing an additional 533,912 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in Revvity by 22.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,612,116 shares of the company’s stock valued at $252,727,000 after purchasing an additional 486,159 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Stock Down 2.2%

Revvity stock opened at $108.04 on Tuesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. Revvity Inc. has a one year low of $81.22 and a one year high of $118.30. The company has a 50-day simple moving average of $105.15 and a 200-day simple moving average of $99.61. The firm has a market capitalization of $12.05 billion, a P/E ratio of 51.69, a P/E/G ratio of 2.17 and a beta of 1.09.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The firm had revenue of $711.12 million for the quarter, compared to the consensus estimate of $704.07 million. During the same period last year, the firm posted $1.01 EPS. Revvity’s quarterly revenue was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, equities analysts expect that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be given a dividend of $0.07 per share. The ex-dividend date is Friday, July 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity’s payout ratio is currently 13.40%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on RVTY shares. Evercore restated an “outperform” rating and issued a $125.00 price target on shares of Revvity in a research report on Monday, July 6th. TD Cowen reaffirmed a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Wolfe Research began coverage on shares of Revvity in a research note on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Wall Street Zen cut shares of Revvity from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Finally, Barclays lifted their target price on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Four investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Revvity currently has a consensus rating of “Hold” and a consensus price target of $108.92.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.